Evidence map›Paper›PMID 18317830›Full record

ArticleMagma (New York, N.Y.)2008

Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.

Federico Boschi, Pasquina Marzola, Marco Sandri, Elena Nicolato, Mirco Galiè, Silvia Fiorini, Flavia Merigo, Vito Lorusso, Linda Chaabane, Andrea Sbarbati

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Magma (New York, N.Y.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019
    Review
  2. Review
  3. Article
  4. Review
  5. In vivo imaging techniques: a new era for histochemical analysis.European journal of histochemistry : EJH · 2016
    Review
  6. Review
  7. Article
  8. B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2014
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Federico BoschiDipartimento di Scienze Morfologico-Biomediche, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy.
Pasquina Marzola
Marco Sandri
Elena Nicolato
Mirco Galiè
Silvia Fiorini
Flavia Merigo
Vito Lorusso
Linda Chaabane
Andrea Sbarbati

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to compare a pure macromolecular contrast agent (Gd-DTPA-albumin) with a new protein-binding blood pool contrast agent (B22956/1) in terms of their capacity to investigate the microvasculature in an experimental model of mammary carcinoma. MATERIALS AND

methodsTumors were induced by subcutaneous injection of 5 x 10(5) BB1 cells into the backs of 5-7 week-old female FVB/neuNT233 mice. The animals were observed using DCE-MRI when the longest diameter of the tumor was 10.2+/-2.0 mm. DCE-MRI experiments were carried out using B22956/1 and (24 h later) Gd-DTPA-albumin.

resultsDCE-MRI data showed that vasculature in the tumor rim was characterized by greater fractional plasma volume and transendothelial permeability than vasculature in the tumor core as measured by both contrast agents. Permeability to Gd-DTPA-albumin in the tumor core was hardly measurable while permeability to B22956/1 was substantial. Histologically the tumor core showed areas of well vascularized, viable tissue surrounded by necrotic regions.

conclusionsDCE-MRI experiments performed with B22956/1 are useful in the investigation of vasculature in those tumor regions that are characterized by low permeability to macromolecules.

Indexed as

AlbuminsGadolinium DTPANeovascularization, PathologicOrganometallic CompoundsAnimalsContrast MediaFemaleImage EnhancementMagnetic Resonance ImagingMammary Neoplasms, ExperimentalMicealbumin-(gadolinium-DTPA)AlbuminsB-22956-1Contrast MediaGadolinium DTPAOrganometallic Compounds

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.